Advanced Search

Chimeric Antigen Receptor T Cell Stocks List

Symbol Grade Name % Change
NTLA C Intellia Therapeutics, Inc. -4.43
ACET F Adicet Bio, Inc. -0.33
NKTX F Nkarta, Inc. -6.77
PSTX F Poseida Therapeutics, Inc. 0.35
HGEN F Humanigen, Inc. -5.70
GRCL F Gracell Biotechnologies Inc. -0.78
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Immune System Chimeric Antigen Receptor Lymphoma Medicine Biopharmaceutical Biotechnology Clinical Medicine Gene Therapy Antigen Biology Cancer Cancer Immunotherapy Cancer Treatments Hematopoietic Stem Cell Immunotherapy Life Sciences Solid Tumors Therapies For Cancer Adoptive Cell Transfer Amyloid

Related ETFs - A few ETFs which own one or more of the above listed Chimeric Antigen Receptor T Cell stocks.

Symbol Grade Name Weight
HELX D Franklin Genomic Advancements ETF 5.96
GNOM D Global X Genomics & Biotechnology ETF 3.96
PBE D PowerShares Dynamic Biotech & Genome 3.51
IDNA D iShares Genomics Immunology and Healthcare ETF 2.76
QMOM D MomentumShares U.S. Quantitative Momentum ETF 2.53
View all Chimeric Antigen Receptor T Cell related ETFs...
Compare ETFs
  • Compare GNOM to PBE
  • Compare HELX to GNOM
  • Compare IDNA to QMOM

    • Recent Signals

    Date Stock Signal Type
    2021-04-19 ACET NR7 Range Contraction
    2021-04-19 ACET Narrow Range Bar Range Contraction
    2021-04-19 GRCL Narrow Range Bar Range Contraction
    2021-04-19 GRCL New 52 Week Closing Low Bearish
    2021-04-19 NKTX Fell Below 20 DMA Bearish
    2021-04-19 NTLA 20 DMA Resistance Bearish
    2021-04-19 NTLA 50 DMA Support Bullish
    2021-04-19 PSTX NR7 Range Contraction
    2021-04-19 PSTX Stochastic Reached Oversold Weakness

    Recent News for Chimeric Antigen Receptor T Cell Stocks

    Date Stock Title
    Apr 19 HGEN Humanigen achieves positive outcome for Lenzilumab in small early-stage study
    Apr 19 HGEN Humanigen Reports Positive Data With Lenzilumab in the ZUMA-19 CAR-T Phase 1b Study in DLBCL and Plans to Initiate a Potential Registrational Study
    Apr 16 NTLA CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
    Apr 16 GRCL Gracell Biotechnologies (GRCL) Investor Presentation - Slideshow
    Apr 15 ACET Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
    Apr 14 ACET Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
    Apr 14 NTLA Is NTLA Stock A Buy or Sell?
    Apr 13 ACET Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research
    Related Industries: Biotechnology
    Related Stock Lists: Immune System Chimeric Antigen Receptor Lymphoma Medicine Biopharmaceutical Biotechnology Clinical Medicine Gene Therapy Antigen Biology Cancer Cancer Immunotherapy Cancer Treatments Hematopoietic Stem Cell Immunotherapy Life Sciences Solid Tumors Therapies For Cancer Adoptive Cell Transfer Amyloid

    Browse All Tags